Aurobindo Pharma arm gets 'Voluntary Action Indicated' classification
Benchmarks Nifty25,221.85177.2FEATURED FUNDS★★★★★UTI Aggressive Hybrid Fund Regular Plan-Growth5Y Return9.73 % Invest NowFEATURED FUNDS★★★★★Motilal Oswal Midcap Fund Direct-Growth5Y Return18.7 % Invest NowEnter search…

Following an inspection from September 7 to September 15, 2026, the US FDA granted Apitoria Pharma, a subsidiary of Aurobindo Pharma, a Voluntary Action Indicated classification. This classification indicates that although objectionable conditions were found in the Telangana manufacturing facility, the absence of immediate regulatory action allows the company to address the issues through voluntary corrective measures.
New Delhi, Drug maker Aurobindo Pharma on Wednesday said its wholly owned subsidiary, Apitoria Pharma, received a "Voluntary Action Indicated" classification for its Telangana API facility from the US health regulator.The US Food and Drug Administration (US FDA) had inspected Unit-II, an active pharmaceutical ingredient (API) manufacturing facility of Apitoria Pharma Pvt Ltd, located at Gaddapotharam, Industrial Development Area -- Kazipally Industrial Area, Jinnaram Mandal in Sangareddy District, Telangana, from September 7-15, 2026.
In a regulatory filing, Aurobindo Pharma said the unit has now received an Establishment Inspection Report (EIR) classifying the facility as "Voluntary Action Indicated" (VAI).
A VAI classification means that objectionable conditions or practices were observed during the inspection, but the agency is not prepared to take or recommend administrative or regulatory action, and corrective measures are left to the company to carry out voluntarily.
Add as a Reliable and Trusted News Source Add Now!
(You can now subscribe to our Economic Times WhatsApp channel)
Read More News onaurobindo pharmaAurobindo PharmaApitoria PharmaUSFDATelangana facilityVoluntary Action Indicatedactive pharmaceutical ingredientEstablishment Inspection ReportGaddapotharamKazipally Industrial Area
(Catch all the Business News, Breaking News and Latest News Updates on The Economic Times.)
...moreless(You can now subscribe to our Economic Times WhatsApp channel)
Read More News onaurobindo pharmaAurobindo PharmaApitoria PharmaUSFDATelangana facilityVoluntary Action Indicatedactive pharmaceutical ingredientEstablishment Inspection ReportGaddapotharamKazipally Industrial Area
(Catch all the Business News, Breaking News and Latest News Updates on The Economic Times.)
...morelessStories you might be interested in
Figures reflect the source report and its stated period. This article is for information and is not investment advice.



